Federated Hermes’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.46M | Buy |
|
|||||
|
2025
Q2 | $614K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $21M | Hold |
|
|||||
|
2024
Q2 | $24.2M | Hold |
|
|||||
|
2024
Q1 | $30.5M | Sell |
|
|||||
|
2023
Q4 | $31.8M | Hold |
|
|||||
|
2023
Q3 | $23.1M | Sell |
|
|||||
|
2023
Q2 | $28.6M | Hold |
|
|||||
|
2023
Q1 | $23M | Hold |
|
|||||
|
2022
Q4 | $20.7M | Hold |
|
|||||
|
2022
Q3 | $33.2M | Sell |
|
|||||
|
2022
Q2 | $35.3M | Hold |
|
|||||
|
2022
Q1 | $36.5M | Hold |
|
|||||
|
2021
Q4 | $44M | Hold |
|
|||||
|
2021
Q3 | $65M | Hold |
|
|||||
|
2021
Q2 | $94M | Sell |
|
|||||
|
2021
Q1 | $71.5M | Sell |
|
|||||
|
2020
Q4 | $97.5M | Sell |
|
|||||
|
2020
Q3 | $64.3M | Sell |
|
|||||
|
2020
Q2 | $79.2M | Hold |
|
|||||
|
2020
Q1 | $45.7M | Sell |
|
|||||
|
2019
Q4 | $76.8M | Buy |
|
|||||
|
2019
Q3 | $35.3M | Buy |
|
|||||
|
2019
Q2 | $39.2M | Buy |
|
|||||
|
2019
Q1 | $27.3M | Hold |
|
|||||
|
2018
Q4 | $21.8M | Hold |
|
|||||
|
2018
Q3 | $33.9M | Buy |
|
|||||
|
2018
Q2 | $37.1M | Buy |
|